Bristol Myers Squibb (BMY) Other Gross PP&E Adjustments (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Other Gross PP&E Adjustments data on file, last reported at -$1.5 billion in Q1 2026.

• Quarterly Other Gross PP&E Adjustments fell 44.97% year-over-year to -$1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 billion (down 44.97% YoY) and the FY2025 annual result came in at -$1.6 billion, down 48.82% from the prior year.
• Other Gross PP&E Adjustments climbed to -$1.5 billion in Q1 2026 per BMY's latest filing, from -$1.6 billion in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at -$678.0 million in Q2 2022 and bottomed at -$1.6 billion in Q4 2025.
• The 5-year median for Other Gross PP&E Adjustments is -$1.2 billion (2024), against an average of -$1.1 billion.
• The widest annual swing landed in 2022, when Other Gross PP&E Adjustments rose 19.0%; it then sank 67.13% in 2023.
• Tracing BMY's Other Gross PP&E Adjustments over 5 years: stood at -$1.1 billion in 2022, then declined by 16.07% to -$1.2 billion in 2023, then climbed by 13.44% to -$1.1 billion in 2024, then tumbled by 48.82% to -$1.6 billion in 2025, then increased by 3.41% to -$1.5 billion in 2026.
• Per Business Quant, the three latest BMY Other Gross PP&E Adjustments figures stand at -$1.5 billion (Q1 2026), -$1.6 billion (Q4 2025), and -$1.4 billion (Q3 2025).

Peer Comparison